According to the Zhitong Finance App, Hengrui Pharmaceutical (01276) announced that on August 3, 2026, the company spent RMB 337.36 million to repurchase 637,000 A-shares, with a repurchase price of RMB 52.87-53.08 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.